Devic’s neuromyelitis optica: a critical review
Open Access
- 1 March 2008
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 66 (1), 120-138
- https://doi.org/10.1590/s0004-282x2008000100034
Abstract
Devic's neuromyelitis optica (NMO) is an idiopathic inflammatory demyelinating and necrotizing disease characterized by predominant involvement of the optic nerves and spinal cord. In Asian countries relapsing NMO has been known as opticospinal multiple sclerosis. It has long been debated if NMO is a variant of multiple sclerosis (MS) or a distinct disease. Recent studies have shown that NMO has more frequently a relapsing course, and results from attack to aquaporin-4 which is the dominant water channel in the central nervous system, located in foot processes of the astrocytes. Distinctive pathological features of NMO include perivascular deposition of IgG and complement in the perivascular space, granulocyte and eosinophil infiltrates and hyalinization of the vascular walls. These features distinguish NMO from other demyelinating diseases such as MS and acute demyelinating encephalomyelopathy. An IgG-antibody that binds to aquaporin-4, named NMO-IgG has high sensitivity and specificity. Magnetic resonance imaging (MRI) studies have revealed that more frequently there is a long spinal cord lesion that extends through three or more vertebral segments in length. Brain MRI lesions atypical for MS are found in the majority of cases. Treatment in the acute phase includes intravenous steroids and plasma exchange therapy. Immunosupressive agents are recommended for prophylaxis of relapses.Keywords
This publication has 99 references indexed in Scilit:
- Immune agents for the treatment of Devic’s neuromyelitis opticaNeurological Sciences, 2007
- Neuromyelitis optica (Devic's disease) in a patient with syphilisMultiple Sclerosis Journal, 2007
- Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibodyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Variable responses to rituximab treatment in neuromyelitis optica (Devic’s disease)Neurological Sciences, 2007
- Fulminant Devic disease successfully treated by lymphocytapheresisJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Aquaporins and brain edemaSurgical Neurology, 2004
- Devic's neuromyelitis optica: A clinicopathological study of 8 patientsAnnals of Neurology, 1993
- Neuromyelitis optica (Devic disease)_following varicella infectionThe Journal of Pediatrics, 1979
- FAMILIAL NEUROMYELITIS OPTICA: ITS OCCURRENCE IN IDENTICAL TWINSBrain, 1938
- ON TWO CASES OF ACUTE MYELITIS ASSOCIATED WITH OPTIC NEURITIS.The Lancet, 1882